Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy

被引:1
|
作者
Schaarschmidt, Benedikt M. [1 ]
Zensen, Sebastian [1 ]
Kesch, Claudia [2 ]
Dertnig, Thomas [1 ]
Opitz, Marcel [1 ]
Drews, Marcel [1 ]
Nadjiri, Jonathan [3 ]
Forsting, Michael [1 ]
Hadaschik, Boris A. [2 ]
Haubold, Johannes [1 ]
机构
[1] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany
[2] Univ Hosp Essen, Dept Urol, Essen, Germany
[3] Tech Univ Munich, Dept Intervent Radiol, Klinikum Rechts Isar, Munich, Germany
关键词
Kidney; Microwave ablation; Radiofrequency ablation; Cryoablation; RADIOFREQUENCY ABLATION; THERMAL ABLATION; HOSPITAL VOLUME; CANCER; CRYOABLATION; ASSOCIATION; GUIDELINES; EXPERIENCE; MANAGEMENT; MORTALITY;
D O I
10.1007/s00330-024-11343-w
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective To evaluate the success and complications of thermal ablation (TA) based on the voluntary, prospective registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) with 303 participating centers from Germany, Austria, and Switzerland. Materials and methods Registry data from 2018 until 2023 of 1102 patients with small renal tumors (age: 72.5 +/- 11.6 years; female: 33.6%, 370/1102) were analyzed. Hospitals with >= 20 TAs were considered high-volume centers. Technical success and complication rates between different parameters were compared using the chi-square or Fisher's exact test, p < 0.05 was considered statistically significant. Results Patients were most frequently treated with radiofrequency ablation (RFA, 43.6%, 481/1102), then microwave ablation (MWA, 41.9%, 462/1102) or cryoablation (13.3%, 147/1102). Technical success for heat-based TA (RFA&MWA) was 94.3% (893/947), for cryoablation 97.3% (143/147). RFA&MWA was significantly more successful in lesions <= 3 cm (96.1%, 567/590) compared to 3-4 cm lesions (89.8%, 97/108; p = 0.005). In patients treated with cryoablation, no significant differences between sizes could be found (<= 3 cm: 97.9%, 94/96; 3-4 cm: 85.7%, 12/14; p = 0.078). Complication rate was significantly higher in RFA&MWA of lesions 3-4 cm compared to <= 3 cm (<= 3 cm: 3.9%, 23/590; 3-4 cm: 11.1%, 12/108, p = 0.002), while no significant differences were seen regarding cryoablation (<= 3 cm: 1.0%, 1/96; 3-4 cm: 0.0%, 0/14; p = 1.000). Conclusions In this exploratory analysis of the DeGIR registry, percutaneous TA of small renal masses is technically feasible with low complication rates. Heat-based TAs seem to have lower success rates and higher complication rates in larger tumors. Cryoablation could potentially be a safe alternative for 3- to 4-cm-sized tumors. Key PointsQuestionHow effective is renal thermal ablation (TA) in terms of treatment success and complication rates?FindingsIn contrast to cryoablation, heat-based thermal ablation has lower success and higher complication rates in tumors measuring 3-4 cm compared to tumors < 3 cm.Clinical relevanceThermal ablation is not influenced by the need for additional techniques such as cooling, protective organ displacement, or temporary vessel occlusion. For small renal tumors, TA is an effective and safe treatment option. Cryoablation could be beneficial in larger tumors.
引用
收藏
页码:1723 / 1731
页数:9
相关论文
共 17 条
  • [1] Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022
    Zensen, Sebastian
    Buecker, Arno
    Meetschen, Mathias
    Haubold, Johannes
    Opitz, Marcel
    Theysohn, Jens M.
    Schramm, Sara
    Jochheim, Leonie
    Kasper, Stefan
    Forsting, Michael
    Schaarschmidt, Benedikt Michael
    EUROPEAN RADIOLOGY, 2024, 34 (05) : 3322 - 3330
  • [2] Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation in Renal Cell Carcinoma
    Gunn, Andrew J.
    Parikh, Nainesh S.
    Bhatia, Shivank
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (02) : 195 - 201
  • [3] Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors
    Ahrar, Kamran
    Wallace, Michael J.
    Matin, Surena F.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (12) : 1735 - 1744
  • [4] Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma
    Morris, Christopher S.
    Baerlocher, Mark O.
    Dariushnia, Sean R.
    McLoney, Eric D.
    Abi-Jaoudeh, Nadine
    Nelson, Kari
    Cura, Marco
    Aal, Ahmed Kamel Abdel
    Mitchell, Jason W.
    Madassery, Sreekumar
    Partovi, Sasan
    McClure, Timothy D.
    Tam, Alda L.
    Patel, Sheena
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (02) : 189 - 194
  • [5] Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors
    Gervais, Debra A.
    Goldberg, S. Nahum
    Brown, Daniel B.
    Soulen, Michael C.
    Millward, Steven F.
    Rajan, Dheeraj K.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (01) : 3 - 8
  • [6] Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis
    Bianchi, Lorenzo
    Chessa, Francesco
    Piazza, Pietro
    Ercolino, Amelio
    Mottaran, Angelo
    Recenti, Dario
    Serra, Carla
    Gaudiano, Caterina
    Cappelli, Alberta
    Modestino, Francesco
    Golfieri, Rita
    Bertaccini, Alessandro
    Marcelli, Emanuela
    Porreca, Angelo
    Celia, Antonio
    Schiavina, Riccardo
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (03) : 222 - 228
  • [7] Position Paper on the Diagnosis and Therapy of peripheral Arterial Disease (PAD) in People with Diabetes mellitus Joint Statement by the German Diabetes Society (DDG), the German Society for Angiology (DGA), the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) and the German Society for Vascular Surgery and Vascular Medicine (DGG)
    Balletshofer, Bernd
    Boeckler, Dittmar
    Diener, Holger
    Heckenkamp, Joerg
    Ito, Wulf
    Katoh, Marcus
    Lawall, Holger
    Malyar, Nasser
    Oberlaender, Yves
    Reimer, Peter
    Rittig, Kilian
    Zaehringer, Markus
    DIABETOLOGIE, 2022, 18 (04): : 402 - 411
  • [8] Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy
    Cai, Huai-Jie
    Fang, Jian-Hua
    Kong, Fan-Lei
    Xu, Chen-Ke
    Chen, Chuang-Hua
    Wang, Wei
    Huang, Bin
    ACTA RADIOLOGICA, 2022, 63 (04) : 553 - 558
  • [9] Perioperative, functional and oncologic outcomes of percutaneous ablation versus minimally invasive partial nephrectomy for clinical T1 renal tumors: outcomes from a pooled analysis
    Li, Kun-peng
    Wan, Shun
    Chen, Si-yu
    Wang, Chen-yang
    Liu, Shan-hui
    Yang, Li
    JOURNAL OF ROBOTIC SURGERY, 2024, 18 (01)
  • [10] Position Paper on the Diagnosis and Therapy of peripheral arterial Occlusive Disease (PAOD) in People with Diabetes mellitus - Joint Statement by the German Diabetes Society (DDG), the German Society for Angiology (DGA), the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR). ) and the German Society for Vascular Surgery and Vascular Medicine (DGG)
    Balletshofer, Bernd
    Boeckler, Dittmar
    Diener, Holger
    Heckenkamp, Joerg
    Ito, Wulf
    Katoh, Marcus
    Lawall, Holger
    Malyar, Nasser
    Qui, Hui Jing
    Reimer, Peter
    Rittig, Kilian
    Zaehringer, Markus
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 : S354 - S364